Available Technologies
Technologies by Dr. Bocheng Wu
Small Molecule Glycosylated Histone Deacetylase Inhibitors (HDACi)
A targeted potential therapy for liver cancer
8373
New Class of Tissue-Targeting Agents Inhibits Fibrosis, Inflammation, and Cancer Growth
A 1,000x more potent idiopathic pulmonary fibrosis (IPF) treatment than currently available
8374
Learn more about Dr. Bocheng Wu